Akoya Biosciences Inc has a share price target of US$ 3, revenue growth forecast of 11.3%, and profit growth estimate of 37.9% for FY25, based on top 8 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature